Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$964,578
+$23,973 QoQ
Shares Held
3,798
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#3,052
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Counsel, Inc holds $4,343,317 across 8 Drug Manufacturers - General names. JNJ ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
984 | $1,180,239 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,798 | $964,578 | |
| 3 | AMGN |
Amgen Inc
|
1,994 | $722,067 | |
| 4 | ABBV |
AbbVie Inc.
|
1,610 | $405,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,713 | $329,183 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,050 | $258,997 | |
| 7 | PFE |
Pfizer Inc
|
10,372 | $249,757 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,816 | $233,356 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $964,578 | 3,798 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $940,605 | 3,848 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $858,428 | 4,148 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $789,889 | 4,260 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,716,200 | 17,782 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,991,753 | 18,040 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,515,664 | 17,395 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,913,838 | 17,980 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,788,732 | 19,080 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,121,567 | 7,090 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,119,123 | 7,140 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,102,087 | 7,076 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,281,455 | 7,742 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,210,085 | 7,807 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,417,086 | 8,022 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,300,672 | 7,962 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $1,421,145 | 8,006 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,383,457 | 7,806 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,333,661 | 7,796 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,249,525 | 7,737 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,193,870 | 7,247 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,078,957 | 6,565 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,101,660 | 7,000 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,101,712 | 7,400 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $984,410 | 7,000 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $999,210 | 7,620 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||